Dorzolamide Hydrochloride And Timolol Maleate Solution/ Drops
Product Images NDC 50383-261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride And Timolol Maleate (NDC 50383-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rotation (Image 01)

Rotation (Image 01)
The text suggests that at a temperature of 25 degrees Celsius and at a concentration of 1 in water, the solution has a certain property which is represented by the symbol "~". This property has a value of approximately negative 17 degrees, which may indicate a freezing point or some other characteristic related to temperature. Additionally, the text mentions a wavelength of 405 nanometers. However, without additional context or information it is difficult to determine the specific nature or significance of these measurements.*
FDA Label Image

Chemical Structure (Image 02)

FDA Label Image

Rotation 2 (Image 03)

FDA Label Image

Chemical Structure 2 (Image 04)

FDA Label Image

Logo (Image 05)

FDA Label Image

Figure A (Image 06)

FDA Label Image

Figure B (Image 07)

FDA Label Image

Figure C (Image 08)

FDA Label Image

Figure D (Image 09)

FDA Label Image

Logo (Image 10)

FDA Label Image

Carton (Image 11)

Carton (Image 11)
This is a description of Dorzolamide HCI/Timolol Maleate Ophthalmic Solution. It is a preservative-free, sterile solution intended for topical application in the eye. Each container of this solution contains 22.3 mg of Dorzolamide Hycrochioride equivalent to 20 mg dorzolamide (2%) and 6.8 mg of Timolol Maleate equivalent to 5 mg timolol (0.5%). The solution comes in single-use containers that are 0.2 mL in volume. The usual dosage is one drop in the morning and one drop in the evening in the affected eye(s). The opened containers should be discarded immediately after use, and any unused single-use containers should be discarded 15 days after opening the pouch. The solution should be stored at 20-25°C (68-77°F) and protected from light.*
FDA Label Image

Logo (Image 12)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.